Latest IMS Health Stories
MUMBAI and MONTREAL, April 20, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its Canadian subsidiary, Lupin Pharma Canada Limited (collectively Lupin)
PHILADELPHIA, April 9, 2015 /PRNewswire/ -- Michelle Troseth, Elsevier Clinical Solutions' Chief Professional Practice Officer, to be honored with
BUENA, N.J., March 26, 2015 /PRNewswire/ -- IGI Laboratories, Inc.
Brad Ryan, M.D., to expand the Apervita community and marketplace across provider, payer, pharmaceutical and device industries Chicago (PRWEB) March 23, 2015
POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Mylan Inc. today announced the U.S.
POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced the U.S.
BANGALORE, February 25, 2015 /PRNewswire/ -- Acceliant, a global technology provider of advanced clinical trial data management solutions, partners with pharma major Lupin
MUMBAI, India and BALTIMORE, February 17, 2015 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A.
-- TPG to Focus Company on Growth and Development of Innovative Products -- DUBLIN and FORT WORTH, Texas, Feb.
Due to the American Psychiatric Association establishing guidelines for diagnosing ADHD in adults in 2013, this trend will likely bolster utilization rates for ADHD drugs from adults over the